HealthNotableSingle-source
4.8
UCB secures US accelerated review for Cimzia, extending flagship drug's lifecycle
Le SoirLO·US · EU·3 days ago
HealthSingle-sourceMedium
5.0
Costa Rica drug access lag hits 7.3 years, above regional average
The WAIT 2026 study shows Costa Rican patients wait 7.3 years for new medicines, up from prior years and above the regional average. This reflects regulatory and reimbursement bottlenecks, likely worsening health outcomes and raising pressure on the health system.
Score Breakdown
Mosaic Score5.0
Confidence0.5
Significance0.5
Source credibility0.3
Related signals
8 foundHealthSingle-source
2.0
Argentina ANMAT halves vaccine release time to 24 hours, 430 batches cleared
BAE Negocios·AR·about 15 hours ago
HealthNotablePartialDeveloping
7.1
Iran pharmacy debt crisis: 77T toman insurance shortfalls disrupt drug supply
IranWire·IR·3 days ago
EnergyHighSingle-sourceBuilding
6.7
Belgian Nuclear Restart at Risk: Doel 3, Tihange 2 Vessel Samples Raise Doubts
Le SoirLO·BE·1 day ago
HealthNotableConfirmedDeveloping
6.4
Crucitas hotspot drives 73% of Costa Rica's malaria cases
Delfino.crLO·CR·about 8 hours ago
MarketsNotableConfirmedDeveloping
6.3
Banco Master Secrecy Breach Hits Brazilian Assets; Ibovespa Falls, Dollar Rises
Valor Econômico·BR·about 12 hours ago
PoliticsNotablePartial
6.3
Costa Rica Education Budget Cut Sparks Expert Backlash Amid Poor PISA Results
Semanario UniversidadLO·CR·about 8 hours ago
PoliticsNotablePartial
5.8
Costa Rica Budget 2027 Cuts Education, Security to Decade Lows; Presidency Spending Rises
Semanario UniversidadLO·CR·3 days ago